Novel Treatments in Newly Diagnosed Multiple Myeloma

January 25, 2019

As an associate editor on the ASCO Post editorial Board, Syed Ali Abutalib, MD, Assistant Medical Director of the Stem Cell Transplant and Cell Therapy Program at Cancer Treatment Centers of America® (CTCA), Chicago, provides regular updates and key findings, along with a fellow colleague, on clinical cancer research, policy news, patient care, and clinical practice issues.

In this review, the doctors share updates on several high-impact selected studies focusing on novel treatments for patients with newly diagnosed multiple myeloma presented at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition.

Read more here (Part 1)

Read more here (Part 2)